Published in Infect Immun on February 01, 2000
Genome-wide analysis of group a streptococci reveals a mutation that modulates global phenotype and disease specificity. PLoS Pathog (2006) 3.68
Inverse relation between disease severity and expression of the streptococcal cysteine protease, SpeB, among clonal M1T1 isolates recovered from invasive group A streptococcal infection cases. Infect Immun (2000) 2.24
Group A Streptococcus transcriptome dynamics during growth in human blood reveals bacterial adaptive and survival strategies. Am J Pathol (2005) 2.05
Genetic switch to hypervirulence reduces colonization phenotypes of the globally disseminated group A streptococcus M1T1 clone. J Infect Dis (2010) 1.57
Analysis of the transcriptome of group A Streptococcus in mouse soft tissue infection. Am J Pathol (2006) 1.53
Induction of group A Streptococcus virulence by a human antimicrobial peptide. Proc Natl Acad Sci U S A (2008) 1.45
Viable group A streptococci in macrophages during acute soft tissue infection. PLoS Med (2006) 1.43
Cleavage of antigen-bound immunoglobulin G by SpeB contributes to streptococcal persistence in opsonizing blood. Infect Immun (2003) 1.04
Mouse skin passage of a Streptococcus pyogenes Tn917 mutant of sagA/pel restores virulence, beta-hemolysis and sagA/pel expression without altering the position or sequence of the transposon. BMC Microbiol (2001) 0.95
Streptococcal inhibitor of complement promotes innate immune resistance phenotypes of invasive M1T1 group A Streptococcus. J Innate Immun (2010) 0.94
Role of CsrR, hyaluronic acid, and SpeB in the internalization of Streptococcus pyogenes M type 3 strain by epithelial cells. Infect Immun (2002) 0.87
Streptococcus pyogenes infection in mouse skin leads to a time-dependent up-regulation of protein H expression. Infect Immun (2003) 0.86
Generation of metabolically diverse strains of Streptococcus pyogenes during survival in stationary phase. J Bacteriol (2009) 0.84
Streptococcal pyrogenic exotoxin B causes mitochondria damage to polymorphonuclear cells preventing phagocytosis of group A streptococcus. Med Microbiol Immunol (2005) 0.81
Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature (1970) 1528.65
Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc Natl Acad Sci U S A (1979) 365.71
A PROTEOLYTIC ENZYME PRODUCED BY GROUP A STREPTOCOCCI WITH SPECIAL REFERENCE TO ITS EFFECT ON THE TYPE-SPECIFIC M ANTIGEN. J Exp Med (1945) 8.50
L-trans-Epoxysuccinyl-leucylamido(4-guanidino)butane (E-64) and its analogues as inhibitors of cysteine proteinases including cathepsins B, H and L. Biochem J (1982) 5.67
A response regulator that represses transcription of several virulence operons in the group A streptococcus. J Bacteriol (1999) 3.81
Hyaluronic acid capsule is a virulence factor for mucoid group A streptococci. Proc Natl Acad Sci U S A (1991) 3.60
A role for trigger factor and an rgg-like regulator in the transcription, secretion and processing of the cysteine proteinase of Streptococcus pyogenes. EMBO J (1998) 3.27
A two-component regulatory system, CsrR-CsrS, represses expression of three Streptococcus pyogenes virulence factors, hyaluronic acid capsule, streptolysin S, and pyrogenic exotoxin B. Infect Immun (1999) 3.15
A conserved Streptococcus pyogenes extracellular cysteine protease cleaves human fibronectin and degrades vitronectin. Microb Pathog (1993) 2.99
Inactivation of Streptococcus pyogenes extracellular cysteine protease significantly decreases mouse lethality of serotype M3 and M49 strains. J Clin Invest (1997) 2.94
Cleavage of interleukin 1 beta (IL-1 beta) precursor to produce active IL-1 beta by a conserved extracellular cysteine protease from Streptococcus pyogenes. Proc Natl Acad Sci U S A (1993) 2.92
Aspects of pathogenesis of serious group A streptococcal infections in Sweden, 1988-1989. J Infect Dis (1992) 2.78
Hyaluronic acid capsule and the role of streptococcal entry into keratinocytes in invasive skin infection. J Clin Invest (1996) 2.57
Molecular analysis of the role of the group A streptococcal cysteine protease, hyaluronic acid capsule, and M protein in a murine model of human invasive soft-tissue infection. J Clin Invest (1998) 2.47
Association of phenotypic and genotypic characteristics of invasive Streptococcus pyogenes isolates with clinical components of streptococcal toxic shock syndrome. Infect Immun (1993) 2.32
Streptococcal cysteine proteinase releases biologically active fragments of streptococcal surface proteins. J Biol Chem (1995) 2.31
Role of mga in growth phase regulation of virulence genes of the group A streptococcus. J Bacteriol (1997) 2.20
Relative contributions of hyaluronic acid capsule and M protein to virulence in a mucoid strain of the group A Streptococcus. Infect Immun (1997) 2.13
Genetic correlates of throat and skin isolates of group A streptococci. J Infect Dis (1996) 2.06
The rgg gene of Streptococcus pyogenes NZ131 positively influences extracellular SPE B production. Infect Immun (1999) 2.06
Extracellular cysteine protease produced by Streptococcus pyogenes participates in the pathogenesis of invasive skin infection and dissemination in mice. Infect Immun (1999) 2.04
Genetic inactivation of an extracellular cysteine protease (SpeB) expressed by Streptococcus pyogenes decreases resistance to phagocytosis and dissemination to organs. Infect Immun (1998) 2.00
Vaccination with streptococcal extracellular cysteine protease (interleukin-1 beta convertase) protects mice against challenge with heterologous group A streptococci. Microb Pathog (1994) 1.98
Association between expression of immunoglobulin G-binding proteins by group A streptococci and virulence in a mouse skin infection model. Infect Immun (1993) 1.92
Characterization of a two-component system in Streptococcus pyogenes which is involved in regulation of hyaluronic acid production. J Biol Chem (1999) 1.90
Temporal production of streptococcal erythrogenic toxin B (streptococcal cysteine proteinase) in response to nutrient depletion. Infect Immun (1997) 1.90
Activation of a 66-kilodalton human endothelial cell matrix metalloprotease by Streptococcus pyogenes extracellular cysteine protease. Infect Immun (1996) 1.90
Protein biotinylation. Methods Enzymol (1990) 1.89
Hyaluronic acid capsule modulates M protein-mediated adherence and acts as a ligand for attachment of group A Streptococcus to CD44 on human keratinocytes. J Clin Invest (1998) 1.87
Role of streptococcal pyrogenic exotoxin B in the mouse model of group A streptococcal infection. Infect Immun (1998) 1.84
Hyaluronate capsule and surface M protein in resistance to opsonization of group A streptococci. Infect Immun (1996) 1.79
Regulation of virulence by environmental signals in group A streptococci: influence of osmolarity, temperature, gas exchange, and iron limitation on emm transcription. Infect Immun (1995) 1.78
Streptococcal cysteine proteinase releases kinins: a virulence mechanism. J Exp Med (1996) 1.77
M-related protein (Mrp) contributes to group A streptococcal resistance to phagocytosis by human granulocytes. Mol Microbiol (1996) 1.71
Specific binding of the activator Mga to promoter sequences of the emm and scpA genes in the group A streptococcus. J Bacteriol (1995) 1.70
Adherence and fibronectin binding are environmentally regulated in the group A streptococci. Mol Microbiol (1993) 1.66
Structural heterogeneity of the emm gene cluster in group A streptococci. Mol Microbiol (1993) 1.64
M protein and protein F act as important determinants of cell-specific tropism of Streptococcus pyogenes in skin tissue. J Clin Invest (1994) 1.60
Effect of group A streptococcal cysteine protease on invasion of epithelial cells. Infect Immun (1998) 1.54
A natural variant of the cysteine protease virulence factor of group A Streptococcus with an arginine-glycine-aspartic acid (RGD) motif preferentially binds human integrins alphavbeta3 and alphaIIbbeta3. Proc Natl Acad Sci U S A (1999) 1.53
Nucleotide sequences of two adjacent M or M-like protein genes of group A streptococci: different RNA transcript levels and identification of a unique immunoglobulin A-binding protein. Infect Immun (1992) 1.53
Genetic linkage of exotoxin alleles and emm gene markers for tissue tropism in group A streptococci. J Infect Dis (1999) 1.52
Molecular evolution of a multigene family in group A streptococci. Mol Biol Evol (1994) 1.49
Identification of pel, a Streptococcus pyogenes locus that affects both surface and secreted proteins. J Bacteriol (1999) 1.39
Allelic polymorphism of emm loci provides evidence for horizontal gene spread in group A streptococci. Proc Natl Acad Sci U S A (1994) 1.38
A secreted streptococcal cysteine protease can cleave a surface-expressed M1 protein and alter the immunoglobulin binding properties. Res Microbiol (1998) 1.36
Severe invasive group A streptococcal disease: clinical description and mechanisms of pathogenesis. J Lab Clin Med (1996) 1.34
The group A streptococcal dipeptide permease (Dpp) is involved in the uptake of essential amino acids and affects the expression of cysteine protease. Mol Microbiol (1998) 1.34
Structure of the has operon promoter and regulation of hyaluronic acid capsule expression in group A Streptococcus. Mol Microbiol (1998) 1.30
Proteolytically active streptococcal pyrogenic exotoxin B cleaves monocytic cell urokinase receptor and releases an active fragment of the receptor from the cell surface. J Biol Chem (1994) 1.28
Streptococcal cysteine protease augments lung injury induced by products of group A streptococci. Infect Immun (1996) 1.25
Analysis of genes encoding two unique type IIa immunoglobulin G-binding proteins expressed by a single group A streptococcal isolate. Infect Immun (1994) 1.20
Effect of mouse passage on Fc receptor expression by group A streptococci. Scand J Immunol (1984) 1.15
Association of type II immunoglobulin G-binding protein expression and survival of group A streptococci in human blood. Infect Immun (1993) 1.10
Immunohistochemical and serological evidence for the role of streptococcal proteinase in acute post-streptococcal glomerulonephritis. Kidney Int (1998) 1.10
Functional and serological analysis of type II immunoglobulin G-binding proteins expressed by pathogenic group A streptococci. J Clin Microbiol (1992) 1.08
Different forms of streptolysin O produced by Streptococcus pyogenes and by Escherichia coli expressing recombinant toxin: cleavage by streptococcal cysteine protease. Infect Immun (1995) 1.07
Production of stabilized virulence factor-negative variants by group A streptococci during stationary phase. Infect Immun (1998) 1.00
Properties of IgG-binding proteins expressed by Streptococcus pyogenes isolates are predictive of invasive potential. J Infect Dis (1996) 0.99
Polymorphism of the streptokinase gene: implications for the pathogenesis of post-streptococcal glomerulonephritis. Zentralbl Bakteriol (1993) 0.98
A group A streptococcal Enn protein potentially resulting from intergenomic recombination exhibits atypical immunoglobulin-binding characteristics. Mol Microbiol (1994) 0.97
DNA sequencing and gene expression of the emm gene cluster in an M50 group A streptococcus strain virulent for mice. Infect Immun (1996) 0.96
Cysteine endopeptidases of parasitic protozoa. Methods Enzymol (1994) 0.95
Serologic evidence for a class I group A streptococcal infection among rheumatic fever patients. J Infect Dis (1995) 0.95
Distinct profiles of immunoglobulin G-binding-protein expression by invasive serotype M1 isolates of Streptococcus pyogenes. Clin Diagn Lab Immunol (1995) 0.85
Molecular markers for throat and skin isolates of group A streptococci. Adv Exp Med Biol (1997) 0.81
Nucleotide sequence analysis of a gene encoding a streptomycin/spectinomycin adenylyltransferase. Plasmid (1985) 4.63
emm typing and validation of provisional M types for group A streptococci. Emerg Infect Dis (1999) 3.12
Group A streptococcal growth phase-associated virulence factor regulation by a novel operon (Fas) with homologies to two-component-type regulators requires a small RNA molecule. Mol Microbiol (2001) 2.24
Cloning, sequence analysis, and expression in Escherichia coli of a streptococcal plasmin receptor. J Bacteriol (1992) 2.14
Association between expression of immunoglobulin G-binding proteins by group A streptococci and virulence in a mouse skin infection model. Infect Immun (1993) 1.92
The potential to use PspA and other pneumococcal proteins to elicit protection against pneumococcal infection. Vaccine (2000) 1.82
Capturing host plasmin(ogen): a common mechanism for invasive pathogens? Trends Microbiol (1994) 1.76
Intranasal vaccination with pneumococcal surface protein A and interleukin-12 augments antibody-mediated opsonization and protective immunity against Streptococcus pneumoniae infection. Infect Immun (2001) 1.74
Identification of a specific receptor for plasmin on a group A streptococcus. Infect Immun (1987) 1.72
M-related protein (Mrp) contributes to group A streptococcal resistance to phagocytosis by human granulocytes. Mol Microbiol (1996) 1.71
Identification of pel, a Streptococcus pyogenes locus that affects both surface and secreted proteins. J Bacteriol (1999) 1.39
Isolation of a prokaryotic plasmin receptor. Relationship to a plasminogen activator produced by the same micro-organism. J Biol Chem (1991) 1.38
A secreted streptococcal cysteine protease can cleave a surface-expressed M1 protein and alter the immunoglobulin binding properties. Res Microbiol (1998) 1.36
Streptococcal Fc receptors. I. Isolation and partial characterization of the receptor from a group C streptococcus. J Immunol (1984) 1.33
Characterization of the interaction of human plasmin with its specific receptor on a group A streptococcus. Microb Pathog (1988) 1.20
Isolation and characterization of type IIa and type IIb Fc receptors from a group A streptococcus. Scand J Immunol (1986) 1.18
Effect of mouse passage on Fc receptor expression by group A streptococci. Scand J Immunol (1984) 1.15
Streptokinase-producing streptococci grown in human plasma acquire unregulated cell-associated plasmin activity. J Infect Dis (1992) 1.15
Identification of non-immunoglobulin A-Fc-binding forms and low-molecular-weight secreted forms of the group B streptococcal beta antigen. Infect Immun (1989) 1.12
Protection of mice from group A streptococcal skin infection by interleukin-12. J Infect Dis (1995) 1.12
Association of type II immunoglobulin G-binding protein expression and survival of group A streptococci in human blood. Infect Immun (1993) 1.10
125I protein A: applications to the quantitative determination of fluid phase and cell-bound IgG. J Immunol Methods (1977) 1.10
Studies on the terminal stages of immune hemolysis. VI. Osmotic blockers of differing Stokes' radii detect complement-induced transmembrane channels of differing size. J Immunol (1979) 1.09
Functional and serological analysis of type II immunoglobulin G-binding proteins expressed by pathogenic group A streptococci. J Clin Microbiol (1992) 1.08
Two novel antigens associated with group B streptococci identified by a rapid two-stage radioimmunoassay. J Infect Dis (1988) 1.07
Measurement of leukocyte chemotaxis in vivo. Methods Enzymol (1988) 1.07
Isolation and partial characterization of a type II Fc receptor from a group A streptococcus. Mol Cell Biochem (1986) 1.07
Streptococcal Fc receptors. II. Comparison of the reactivity of a receptor from a group C streptococcus with staphylococcal protein A. J Immunol (1984) 1.06
Evidence for functional heterogeneity in IgG Fc-binding proteins associated with group A streptococci. J Immunol (1991) 1.05
Group B streptococcal C protein-associated antigens: association with neonatal sepsis. J Infect Dis (1991) 1.04
Immune responses to specific antigens of Streptococcus pneumoniae and Moraxella catarrhalis in the respiratory tract. Infect Immun (2000) 1.03
Identification of two type IIa IgG-binding proteins expressed by a single group A streptococcus. J Immunol (1992) 1.02
Mapping of the human plasmin domain recognized by the unique plasmin receptor of group A streptococci. Infect Immun (1989) 1.02
Studies on the terminal stages of immune hemolysis. III. Distinction between the insertion of C9 and the formation of a transmembrane channel. J Immunol (1978) 1.02
Interaction between group A streptococci and the plasmin(ogen) system promotes virulence in a mouse skin infection model. J Infect Dis (1999) 0.99
Properties of IgG-binding proteins expressed by Streptococcus pyogenes isolates are predictive of invasive potential. J Infect Dis (1996) 0.99
Detection of receptors for the Fc region of IgG on streptococci. J Immunol Methods (1983) 0.99
Isolated DNA repeat region from fcrA76, the Fc-binding protein gene from an M-type 76 strain of group A streptococci, encodes a protein with Fc-binding activity. Mol Microbiol (1990) 0.99
Identification of a unique receptor on a group A streptococcus for the Fc region of human IgG3. J Immunol (1986) 0.98
A role for fibrinogen in the streptokinase-dependent acquisition of plasmin(ogen) by group A streptococci. J Infect Dis (1995) 0.98
The potential role for nephritis-associated plasmin receptor in acute poststreptococcal glomerulonephritis. Methods (2000) 0.98
Invasive Streptococcus pneumoniae isolates from Argentinian children: serotypes, families of pneumococcal surface protein A (PspA) and genetic diversity. Epidemiol Infect (2004) 0.97
A group A streptococcal Enn protein potentially resulting from intergenomic recombination exhibits atypical immunoglobulin-binding characteristics. Mol Microbiol (1994) 0.97
Analysis of the interaction of group A streptococci with fibrinogen, streptokinase and plasminogen. Microb Pathog (1995) 0.97
Studies on the interaction between protein A and immunoglobulin G. II. Composition and activity of complexes formed between protein A and IgG. J Immunol (1978) 0.96
Nerve growth factor: a chemotactic factor for polymorphonuclear leukocytes in vivo. J Immunol (1985) 0.96
Studies on the terminal stages of immune hemolysis. V. Evidence that not all complement-produced transmembrane channels are equal. J Immunol (1979) 0.96
New name for the positive regulator of the M protein of group A streptococcus. Mol Microbiol (1995) 0.95
Differences in cell-bound C8 sites on chicken erythrocytes measured by their reactivity with guinea pig and human C9. J Immunol (1980) 0.95
Identification of key gene products required for acquisition of plasmin-like enzymatic activity by group A streptococci. J Infect Dis (1997) 0.95
Mouse skin passage of a Streptococcus pyogenes Tn917 mutant of sagA/pel restores virulence, beta-hemolysis and sagA/pel expression without altering the position or sequence of the transposon. BMC Microbiol (2001) 0.95
Lysis of tumor cells by antibody and complement. VII. Complement-dependent 86Rb release--a nonlethal event? J Immunol (1976) 0.94
Production of Brucella abortus-specific protein A-reactive antibodies (IgG2) in infected and vaccinated cattle. Vet Microbiol (1986) 0.94
Analysis of plasmin(ogen) acquisition by clinical isolates of group A streptococci incubated in human plasma. J Infect Dis (1994) 0.94
Nerve growth factor: stimulation of polymorphonuclear leukocyte chemotaxis in vitro. Proc Natl Acad Sci U S A (1983) 0.94
Construction and oral immunogenicity of a Salmonella typhimurium strain expressing a streptococcal adhesin linked to the A2/B subunits of cholera toxin. Vaccine (1996) 0.93
Urokinase: a chemotactic factor for polymorphonuclear leukocytes in vivo. J Immunol (1987) 0.93
Studies on the terminal stages of antibody-complement-mediated killing of a tumor cell. II. Inhibition of transformation of T to dead cells by 3'5' cAMP. J Immunol (1976) 0.92
A simple procedure to use whole serum as a source of either IgG- or IgM-specific antibody. J Immunol Methods (1980) 0.92
Similarities between complement-mediated and streptolysin S-mediated hemolysis. J Biol Chem (2001) 0.91
Analysis of surface receptor expression on bacteria isolated from patients with endocarditis. J Gen Microbiol (1986) 0.90
Interaction between components of the human classical complement pathway and immobilized Cibacron Blue F3GA. J Immunol Methods (1979) 0.90
Streptococcal pyrogenic exotoxin B enhances tissue damage initiated by other Streptococcus pyogenes products. J Infect Dis (2001) 0.90
The terminal stages of immune hemolysis--a brief review. Mol Immunol (1980) 0.89
A rapid technique for measuring leukocyte chemotaxis in vivo. J Immunol Methods (1984) 0.89
Identification of protein A from Staphylococcus intermedius isolated from canine skin. Am J Vet Res (1988) 0.89
Species specificity of plasminogen activation and acquisition of surface-associated proteolytic activity by group C streptococci grown in plasma. Infect Immun (1999) 0.89
Analysis of immunoglobulin G-binding-protein expression by invasive isolates of Streptococcus pyogenes. Clin Diagn Lab Immunol (1995) 0.88
Analysis of expression of a cytosolic enzyme on the surface of Streptococcus pyogenes. Biochem Biophys Res Commun (2000) 0.88
Studies on the terminal stages of immune hemolysis. IV. Effect of metal salts. J Immunol (1979) 0.88
Interaction of a group A Streptococcus within human plasma results in assembly of a surface plasminogen activator that contributes to occupancy of surface plasmin-binding structures. Microb Pathog (1998) 0.87
Lysis of tumor cells by antibody and complement. VI. Enhanced killing of enzyme-pretreated tumor cells. J Immunol (1976) 0.87
A pivotal role for interferon-gamma in protection against group A streptococcal skin infection. J Infect Dis (2000) 0.86
Comparison of type III Fc receptors associated with group C and group G streptococci. Mol Immunol (1986) 0.86
Studies on the terminal stages of antibody-complement-mediated killing of a tumor cell. I. Evidence for the existence of an intermediate, T. J Immunol (1976) 0.85
Results of the premature birth national need-gap study. J Perinatol (2007) 0.85
Studies on the interaction between protein A and immunoglobulin G. I. Effect of protein A on the functional activity of IgG. J Immunol (1978) 0.85
Distinct profiles of immunoglobulin G-binding-protein expression by invasive serotype M1 isolates of Streptococcus pyogenes. Clin Diagn Lab Immunol (1995) 0.85
Clinical isolates of Streptococcus pneumoniae resistant to levofloxacin contain mutations in both gyrA and parC genes. Int J Antimicrob Agents (2001) 0.84
Distinction between C8-mediated and C8/C9-mediated hemolysis on the basis of independent 86Rb and hemoglobin release. J Immunol (1980) 0.84
Enzyme-labeled type III bacterial Fc receptors. A versatile tracer for immunoassay. J Immunol Methods (1988) 0.84
Identification of distinct Fc-receptor molecules on streptococci and staphylococci. J Clin Lab Immunol (1984) 0.84
Restoration of complement function in vivo by plasma infusion in factor I (C3b inactivator) deficiency. J Pediatr (1984) 0.84
Role of staphylokinase in the acquisition of plasmin(ogen)-dependent enzymatic activity by staphylococci. J Infect Dis (1996) 0.84
Inactivation of single genes within the virulence regulon of an M2 group A streptococcal isolate result in differences in virulence for chicken embryos and for mice. Microb Pathog (1997) 0.84
The destruction of allogeneic tumour cells by antibody and adherent cells from peritoneal cavities of mice. Cell Immunol (1976) 0.83
Interaction of group A streptococci with human plasmin(ogen) under physiological conditions. Methods (2000) 0.83
Detection of streptococcal class I M protein in psoriasis by confocal immunofluorescent microscopy. Acta Derm Venereol (1997) 0.83
Immune response to surface protein A of Streptococcus pneumoniae and to high-molecular-weight outer membrane protein A of Moraxella catarrhalis in children with acute otitis media. J Infect Dis (2000) 0.83
Group A streptococci bind human plasmin but not other structurally related proteins. Thromb Res (1989) 0.82
The destruction of tumor cells by alloimmune peritoneal cells: mechanism of action of activated macrophages in vitro. J Reticuloendothel Soc (1975) 0.82
Nerve growth factor: activation of the classical complement pathway by specific substitution for component C1-. Proc Natl Acad Sci U S A (1982) 0.81
Group A streptococcal isolate 64/14 expresses surface plasmin-binding structures in addition to Plr. Res Microbiol (1998) 0.81
Evidence for a temperature-dependent and temperature-independent pathway in the generation of complement-mediated transmembrane channels. Biochem Biophys Res Commun (1980) 0.80
The destruction of allogeneic tumour cells by peritoneal macrophages from immune mice: purification of lytic effector cells. Cell Immunol (1975) 0.80
Comparison of albumin receptors expressed on bovine and human group G streptococci. Infect Immun (1991) 0.80
Different alleles of the fcrA/mrp gene of Streptococcus pyogenes encode M-related proteins exhibiting an identical immunoglobulin-binding pattern. Med Microbiol Immunol (1996) 0.80
Inactivation of the proteolytic activity of mouse nerve growth factor by human C1(activated)-inhibitor. J Immunol (1987) 0.79
Antibody-complement killing of neuroblastoma cells. Prog Clin Biol Res (1985) 0.79
Colloidal gold immunolabeling of immunoglobulin-binding sites and beta antigen in group B streptococci. Infect Immun (1990) 0.79